Creative Medical Technolo...

NASDAQ: CELZ · Real-Time Price · USD
3.05
-0.02 (-0.65%)
At close: Aug 15, 2025, 3:59 PM
3.12
2.30%
After-hours: Aug 15, 2025, 06:53 PM EDT

Creative Medical Technology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
6K 14K 11K 11K 17K 9K 9K 24.6K 73.6K 83.6K 98.6K 147.75K 102.75K 102.75K 87.75K 37.5K 104.5K 122.4K
Cost of Revenue
-25.4K -23.67K 4.4K 29.92K 90.86K 81.41K 75.16K 54.14K 67.74K 49.22K 32.99K 66.74K 54.74K 54.74K 70.97K 39.52K 53.12K 59.42K
Gross Profit
31.4K 37.67K 6.6K -18.92K -73.86K -72.41K -66.16K -29.54K 5.86K 34.38K 65.61K 81.01K 48.01K 48.01K 16.78K -2.02K 51.38K 62.98K
Operating Income
-5.92M -6.28M -5.74M -5.63M -6.06M -5.63M -5.62M -10.13M -9.6M -10.2M -10.24M -5.44M -5.25M -3.98M -3.13M -1.98M -1.39M -1.08M
Interest Income
153.8K 191.16K 250.38K 311.99K 331.68K 354.01K 333.61K 302.59K 251.44K 161.53K 100.33K 38.08K n/a n/a n/a n/a n/a n/a
Pretax Income
-5.77M -6.09M -5.49M -5.32M -5.73M -5.28M -5.29M -9.82M -9.35M -10.04M -10.14M -7.8M -8.67M -9.78M 19.21M -15.53M -13.29M -12.23M
Net Income
-5.77M -6.09M -5.49M -5.32M -5.73M -5.28M -5.23M -9.7M -9.23M -10.15M -10.32M -8.04M -8.9M -9.78M 19.21M -15.53M -13.29M -12.23M
Selling & General & Admin
3.51M 3.46M 3.24M 3.24M 3.28M 3.46M 3.56M 3.06M 3.34M 3.58M 3.94M 4.47M 4.42M 3.81M 2.96M 1.85M 1.38M 1.1M
Research & Development
2.3M 2.72M 2.4M 2.28M 2.69M 2.07M 1.97M 6.99M 6.23M 6.58M 6.27M 950.63K 778.88K 119.18K 109.18K 59.18K n/a n/a
Other Expenses
51.91K 51.91K 51.91K 29.27K 23.02K 23.02K 46.04K 69.06K 46.04K 69.06K 69.06K -23.02K n/a n/a n/a 85.83K 79.58K 73.04K
Operating Expenses
5.86M 6.23M 5.69M 5.55M 5.99M 5.58M 5.6M 10.14M 9.66M 10.25M 10.3M 5.51M 5.29M 4.02M 3.17M 2M 1.46M 1.17M
Interest Expense
n/a n/a n/a n/a n/a n/a 50.00 50.00 50.00 50.00 n/a 2.4M 3.71M 3.94M 4.28M 2.2M 1.18M 1.24M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -30.38K -30.38K -30.38K
Cost & Expenses
5.89M 6.26M 5.75M 5.64M 6.08M 5.64M 5.63M 10.15M 9.68M 10.28M 10.33M 5.58M 5.34M 4.08M 3.21M 2.01M 1.49M 1.21M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -61.15K -123.39K -123.39K 110.95K 172.09K 234.34K 234.34K n/a n/a 319.35K 319.35K 319.35K
Shares Outstanding (Basic)
2.58M 1.98M 1.65M 1.39M 1.41M 1.42M 1.39M 1.43M 1.41M 1.41M 1.41M 1.41M 901.13K 645.4K 348.12K 245.21K 232.01K 227.71K
Shares Outstanding (Diluted)
2.58M 1.98M 1.65M 1.39M 1.41M 1.42M 1.39M 1.43M 1.41M 1.41M 1.41M 1.41M 901.13K 645.4K 633.89K 245.21K 232.01K 248.91K
EPS (Basic)
-3.18 -3.81 -3.71 -3.8 -4.07 -3.74 -3.71 -6.87 -6.55 -8.02 -9.11 -15.87 -22.69 -32.96 91.03 -149.1 -135.78 -177.72
EPS (Diluted)
-3.18 -3.81 -3.71 -3.8 -4.07 -3.74 -3.71 -6.87 -6.55 -8.02 -9.11 -10.85 -17.67 -27.94 85.65 -159.5 -150.58 -192.52
EBITDA
-5.74M -6.14M -5.52M -5.44M -5.87M -5.45M -5.46M -9.91M -9.39M -9.99M -10.09M -5.35M -5.16M -3.88M -3.03M -1.89M -1.31M -1.01M
EBIT
-5.97M -6.36M -5.74M -5.55M -5.98M -5.55M -5.56M -10M -9.48M -10.08M -10.18M -5.44M -4.96M -5.84M 23.49M -13.34M -12.12M -10.99M
Depreciation & Amortization
113.23K 111.76K 110.45K 113.33K 107.08K 100.83K 94.58K 92.08K 92.08K 92.08K 92.08K 92.08K 92.08K 92.08K 92.08K 85.83K 79.58K 73.04K